These ion transporter and ASL responses to estrogen occur as a non-genomic effect via ERα and may underlie estrogen effects in vivo to exacerbate lung function especially in CF, when secretion is already compromised through the lack of functional CFTR. The gene discussed is ESR1; the disease is cystic fibrosis.